Exercise capacity impairment in COPD patients with comorbidities

被引:6
|
作者
Da Silva, G. P. F. [1 ,3 ]
Pessoa Morano, M. T. A. [2 ]
De Matos Cavalcante, A. G. [1 ]
De Andrade, N. M. [1 ]
De Francesco Daher, E. [1 ]
Pereira, E. D. B. [1 ]
机构
[1] Univ Fed Ceara UFC, Fortaleza, Ceara, Brazil
[2] Hosp Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil
[3] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil
关键词
Exercise capacity; Health status; COPD; Comorbidity; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ARTERIAL STIFFNESS; EMPHYSEMA; MORTALITY; ANXIETY; IMPACT; INTERVENTION;
D O I
10.1016/j.rppnen.2015.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity. Objective: to evaluate the impact of comorbidities on functional capacity of COPD patients. Methods: a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having "none", "one" and "two or three'' comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT. Results: Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 +/- 8 years and 55% were male. CAT scores increased from "no comorbidity" (17.9 +/- 7.7) to "one comorbidity" (22.8 +/- 6.8) and "two or three comorbidities" groups (24.2 +/- 10.2). A post hoc test showed a significant difference in the "no comorbidity" compared to the "two or three comorbidities" groups (p = 0.01). The distance walked by the patients decreased from "no comorbidity" (386.1 +/- 83.2 m) to "one comorbidity" (350 +/- 98 m) and "two or three comorbidities" groups (312.6 +/- 91 m). A post hoc test showed significant difference in the "no comorbidity" compared to "two or three comorbidities" groups (p = 0.007). Numbers of comorbidities were independently associated with the 6 MWT adjusting for age, severity of COPD and CAT scores. Conclusion: in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD. (C) 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
下载
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [1] Determinants of exercise capacity in patients with COPD without other comorbidities
    Samperiz, Gloria
    Madre, Laura
    Cubero, Pablo
    Forner, Marta
    Forcen, Elena
    Carrizo, Santiago
    Marin, Jose M.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Arterial stiffness contributes to physical exercise capacity impairment in COPD patients
    Castagna, Olivier
    Nussbaum, Eric
    Marqueste, Louis
    Boussuges, Alain
    CHEST, 2006, 130 (04) : 246S - 246S
  • [3] Exercise capacity and comorbidities in patients with obstructive sleep apnea
    Vitacca, Michele
    Paneroni, Mara
    Braghiroli, Alberto
    Balbi, Bruno
    Aliani, Maria
    Guido, Patrizia
    Fanfulla, Francesco
    Pertosa, Mario
    Ceriana, Piero
    Zampogna, Elisabetta
    Raccanelli, Rita
    Sarno, Nicola
    Spanevello, Antonio
    Maniscalco, Mauro
    Malovini, Alberto
    Ambrosino, Nicolino
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2020, 16 (04): : 531 - 538
  • [4] Comorbidities and exercise capacity in older patients with intermittent claudication
    Katzel, LI
    Sorkin, JD
    Powell, CC
    Gardner, AW
    VASCULAR MEDICINE, 2001, 6 (03) : 157 - 162
  • [5] Exercise capacity and lobar hyperinflation in patients with COPD
    Leemans, Glenn
    Ides, Kris
    Van Holsbeke, Cedric
    Vos, Wim
    De Backer, Jan
    De Backer, Wilfried
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] Exercise capacity in patients with heart failure and COPD
    Diaz Molina, B.
    Iscar, M.
    Lambert, J. L.
    Quezada, C. A.
    Renilla, A.
    Benito, E.
    Secades, S.
    Bernardo, M. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S159 - S159
  • [7] DYSPNEA AND INSPIRATORY CAPACITY ON EXERCISE IN PATIENTS WITH COPD
    NOSEDA, A
    CARPIAUX, JP
    SCHMERBER, J
    YERNAULT, JC
    REVUE DES MALADIES RESPIRATOIRES, 1993, 10 (06) : 537 - 543
  • [8] Exercise Performance as a Predictor for Balance Impairment in COPD Patients
    Liwsrisakun, Chalerm
    Pothirat, Chaicharn
    Chaiwong, Warawut
    Bumroongkit, Chaiwat
    Deesomchok, Athavudh
    Theerakittikul, Theerakorn
    Limsukon, Atikun
    Tajarernmuang, Pattraporn
    Phetsuk, Nittaya
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [9] Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
    Mandal, Jyotshna
    Roth, Michael
    Papakonstantinou, Eleni
    Tamm, Michael
    Boeck, Lucas
    Scherr, Andreas
    Rakic, Janko
    Louis, Renaud
    Milencovic, Branislava
    Boersma, Wim
    Kostikas, Konstantinos
    Blasi, Francesco
    Aerts, Joachim
    Rohde, Gernot
    Lacoma, Alicia
    Torres, Antoni
    Welte, Tobias
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Comorbidities in Patients With COPD
    Mohammadien, Hamdy
    Hussein, Mona
    Ahmad, Olaa
    CHEST, 2016, 150 (04) : 914A - 914A